Company reports resilient performance in the nine months to date: revenue from operations up 17% to Rs 2,572 crores, PAT up 16% to Rs 330 crores (before exceptional items) Syngene International Limited today announced its third quarter financial results. Reported revenue from operations for the quarter
Thermo Fisher Scientific, the world leader in serving science, announces the appointment of Srinath Venkatesh as Managing Director, India and South Asia, for the company. Srinath Venkatesh steps into this pivotal role with a vision to advance Thermo Fisher's growth and operations in India, while enhancing
The funds will be utilized to expand HempStreet’s product range and further build upon the company’s capabilities towards solving menstrual (Dysmenorrhea) pain -The company projects a 100% revenue growth for the financial year 2023 -24 HempStreet, India's first research to retail venture in the ayurvedic cannabis sector, has raised
Need for stronger private collaborations, community engagement to extend healthcare access to every women: Additional Secretary & DG (CGHS), MoHFW Ms Roli Singh, Additional Secretary & DG (CGHS), Ministry of Health and Family Welfare, Govt of India while applauding the progress made so far in terms of
Obtaining market authorization for Bleomycin from MHRA is a momentous accomplishment for Venus Pharma GmbH. Venus Remedies holds a total of 15 Market Authorizations (MA) for Bleomycin products across the globe. Venus Remedies is thrilled to announce the achievement of market authorization in the United Kingdom
Program partners with government hospitals to strengthen drug development in the country Roche Pharma India, world’s leading biopharmaceutical company today announced the launch of its Clinical Trial Excellence project in India with an objective to strengthen the capabilities of public health institutions to do clinical trials
Shows noble and ambitious intent of PM Narendra Modi: Rajiv Nath Association of Indian Medical Industry (AiMeD) Forum Coordinator Rajiv Nath has hailed Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) Scheme as a “noble and ambitious intent” of Prime Minister Narendra Modi,
This facility is expected to have a profound impact, benefiting approximately 9,000 villagers from Chinthapalli and four neighboring villages. It is designed to foster collaboration and facilitate a variety of community-centric initiatives that will contribute to the overall development of the region. Aurobindo Pharma Foundation
MrMed, a leading online super-specialty pharmacy, announced funding of $500,000 from Tamil Nadu Emerging Sector Seed Fund (TNESSF), managed by Tamil Nadu Infrastructure Fund Management Corporation Limited. The seed fund, initiated by the Government of Tamil Nadu, seeks to empower startups and ventures in emerging
The company expects this marketing approval to enable it to rapidly expand its operations not only in Saudi Arabia, the largest pharma market in GCC region, but other GCC and MENA countries as well The marketing authorisation from Saudi Arabia comes as an evident
